/PRNewswire/ Talphera, Inc. (Nasdaq: TLPH), ("Talphera"), a specialty pharmaceutical company focused on the development and commercialization of innovative.
/PRNewswire/ Today, Jefferson Health announced the opening of the Stephen and Sandra Sheller Consult and Bridge Program. The Bridge Program is an ecosystem.
/PRNewswire/ TIME has named Yale School of Medicine immunobiologist Dr. Akiko Iwasaki to the 2024 TIME100 Health, the magazine s annual list of the 100 most.